Department of Pharmaceutical Sciences, College of Pharmacy, Nursing and Allied Sciences, North Dakota State University, Department 2665, PO Box 6050, Fargo, ND 58108-6050, USA.
Small. 2013 Jun 24;9(12):2129-39. doi: 10.1002/smll.201202655. Epub 2013 Jan 29.
The ability to map multiple biomarkers at the same time has far-reaching biomedical and diagnostic applications. Here, a series of biocompatible poly(D,L-lactic-co-glycolic acid) and polyethylene glycol particles for multicolor and multiplexed imaging are reported. More than 30 particle formulations that exhibit distinct emission signatures (ranging from the visible to NIR wavelength region) are designed and synthesized. These particles are encapsulated with combinations of carbocyanine-based fluorophores DiO, Dil, DiD, and DiR, and are characterized as <100 nm in size and brighter than commercial quantum dots. A particle formulation is identified that simultaneously emits fluorescence at three different wavelengths upon a single excitation at 485 nm via sequential and multiple FRET cascade events for multicolor imaging. Three other particles that display maximum fluorescence intensities at 570, 672, or 777 nm for multiplexed imaging are also identified. These particles are individually conjugated with specific (Herceptin or IgG2A11 antibody) or nonspecific (heptaarginine) ligands for targeting and, thus, could be applied to differentiate different cancer cells from a cell mixture according to the expressions of cell-surface human epidermal growth factor receptor 2 and the receptor for advanced glycation endproducts. Using an animal model subcutaneously implanted with the particles, it is further demonstrated that the developed platform could be useful for in vivo multiplexed imaging.
同时绘制多种生物标志物的能力具有深远的生物医学和诊断应用。在这里,报道了一系列生物相容性的聚(D,L-丙交酯-共-乙交酯)和聚乙二醇颗粒,用于多色和多重成像。设计和合成了 30 多种具有不同发射特征的颗粒制剂(从可见到近红外波长区域)。这些颗粒封装有基于碳菁的荧光染料 DiO、Dil、DiD 和 DiR 的组合,并具有小于 100nm 的尺寸和比商业量子点更亮的特点。通过连续和多次 FRET 级联事件,在 485nm 单激发下,一种颗粒制剂能够同时在三个不同波长处发出荧光,用于多色成像。还鉴定了另外三种在 570、672 或 777nm 处显示最大荧光强度的颗粒,用于多重成像。这些颗粒分别与特定的(曲妥珠单抗或 IgG2A11 抗体)或非特异性(七精氨酸)配体缀合,用于靶向,因此可以根据细胞表面人表皮生长因子受体 2 和晚期糖基化终产物受体的表达,从细胞混合物中区分不同的癌细胞。在皮下植入这些颗粒的动物模型中进一步证明,所开发的平台可用于体内多重成像。